The Oxford-Harrington Rare Disease Centre, a partnership between Harrington Discovery Institute and the University of Oxford, is redefining what’s possible in rare disease research. Together, we are advancing scientific breakthroughs and turning them into potential cures.

Join us for a special webinar with Dr. Angela Russell, Oxford-Harrington Rare Disease Scholar, who is pioneering a new treatment path for Duchenne muscular dystrophy, and Dr. Michael Pacold, Oxford-Harrington Rare Disease Scholar, who is developing an innovative therapy for HDPL Encephalopathy.

This event is an opportunity to:

• Hear directly from a leading researcher on the front lines of rare disease discovery.
• See how the Oxford-Harrington Rare Disease Centre is accelerating the path from lab to patient.
• Learn how philanthropy and global collaboration are making cures possible.

Be part of the story. Discover how Harrington and Oxford are shaping the future of medicine.